Centre for disease control and prevention calls for new tact to deal with threatening delta variant

US – The Centre for Disease Control and Prevention (CDC), believe that the war against COVID-19 has changed because of the highly contagious delta variant. CDC proposed the need for a clearer message regarding COVID-19 information, mandatory vaccines for health workers and a return to universal masking. The organization documented the detriment of the contagious delta variant which is dominant across the globe and is as contagious as chickenpox and far more contagious than the common cold or flu. According to the CDC, the Delta variant has mutations on the…

Read More

An estimated 1.5 million children have lost parents due to the pandemic

WORLD – A new joint global study led by the United States Centers for Disease Control and Prevention and published in the Lancet reveals that during the first 14 months of the COVID-19 pandemic, at least 1.5 million children lost a parent, custodial grandparent, or other caregiver due to COVID-19. The study published in a Lancet report used mortality and fertility data to model minimum estimates and rates of COVID-19-associated deaths of primary or secondary caregivers for children younger than 18 years in 21 countries. Based on the study, an…

Read More

GE Healthcare’s serena bright now in five major hospitals across the United States

US – GE Healthcare, a leading global medical technology and digital solutions innovator, has installed Serena Bright, the industry’s first contrast-guided biopsy solution, helping empower clinicians and patients in their fight against breast cancer, in five hospitals across the United States (US). The technology received U.S. Food and Drug Administration 510(k) clearance in May 2020, will allow patients to have their breast biopsy exams with contrast guidance using the same mammography equipment, in the same room, and with the same staff as the screening or diagnostic mammogram. Among others, Serena…

Read More

Genome sequencing labs growth trend witnessed globally as India launches second facility at the Institute of Liver and Biliary Services

WORLD – The Institute of liver and Biliary Services will now have the privilege to house a second genome sequencing facility in India after the Chief minister of India, Arvind Kejriwal inaugurated its launch. This facility alongside the other one launched at Lok Nayak Hospital will reduce India’s dependency on National Centre for Disease Control (NCDC) when it comes to testing of samples. ILBS facility will be able to sequence nearly all 30000 molecules of SARS CoV2 with the help of the latest machines called NextSeq and MiSeq that can…

Read More

US department of defense injects US$2.9M to Ischemix for its phase one trial of traumatic brain injury drug

US – Ischemix, a privately owned company focused on developing therapeutics for serious medical conditions, has received funding worth US$2.9M from the US department of defense (USDoD) to conduct its phase 1 study of a traumatic brain injury (TBI) drug. This fund was granted by US Army Medical Research and Development Command (USAMRDC), Combat Casualty Care Research Program (CCCRP) in collaboration with the Medical Technology Enterprise Consortium (MTEC), a 501(c)(3) biomedical technology consortium. The funding is meant pay for a substantial portion of manufacturing and formulating additional supply of the…

Read More

WHO gives new recommendations for screening and treatment of cervical cancer as decline in screening of breast and cervical cancer witnessed

SWITZERLAND – World Health Organization (WHO) and Human Reproduction Programme (HRP) have launched new guidelines to help countries make faster progress, more and equitably, on the screening and treatment of cancer. The guidelines includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendations and 7 good practice statements. Among the 23 recommendations, 6 are identical for both the general population of women and for women living with HIV and 12 are different and specific for each population. For the 7 good practice…

Read More

Sanofi’s and translate bio’s mRNA influenza vaccine now in its first phase clinical trials

US – Sanofi Pasteur, the vaccine global unit of Sanofi and Translate bio, is initiating the first phase clinical trials of its mRNA influenza vaccine. This is a move that proceeds positive preclinical safety and immunogenicity data of the mRNA vaccines which will assess the safety and immunogenicity (immune response) of the monovalent (single-strain) vaccine candidate in up to 280 participants.  The development of this vaccine has been ongoing since a joint venture collaboration between Translate Bio and Sanofi Pasteur that involved an exclusive license agreement that has been ongoing…

Read More

Health experts to review heart related complications among teens post their COVID jab

WORLD – A panel of health experts convened by the US health agency will meet to review data surrounding more than 300 confirmed cases of heart inflammation among adolescents and young adults after receiving mRNA COVID vaccines. The committee, hosted by the Centers for Disease Control and Prevention (CDC), will hear a risk-benefit analysis as researchers probe the shots’ probable links to myocarditis, an inflammation of the heart muscle. This emergency review comes after 11, 323 people under the age of 29 who received mRNA COVID vaccines presented to have…

Read More

CureVac’s vaccine proves to have a 47% efficacy rating after its preliminary results

EUROPE – The German company CureVac provided disappointing preliminary results from a clinical trial of its COVID-19 vaccine, dimming hopes that it could help fill the world’s current greatest need. The trial, which included 40,000 volunteers in Latin America and Europe, estimated that CureVac’s mRNA vaccine had an efficacy of just 47 percent, among the lowest reported so far from any COVID-19 vaccine maker. Results released were based on data from 135 volunteers who got sick with COVID-19 as an independent panel compared the number of sick people who had…

Read More

CDC study shows mRNA COVID-19 vaccines are 94% effective in health care personnel

U.S – New C0VID-19 vaccines effectiveness study conducted by CDC shows that mRNA vaccines by Pfizer-Biotech and Moderna reduce ri According to the study, the FDA approved vaccines reduced the risk of contracting SARS-CoV-2 virus by 94% among health care workers who were fully vaccinated. This study is the largest one to date, covering a sample size distribution of 500,000 health care personnel across 25 U.S. states, provides concrete evidence that C0VID-19 vaccines are performing as expected in the real world. Compared to the earlier study by CDC  on health…

Read More